W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT
|
Back to Search Results |
|
Catalog Number HT066080 |
Device Problem
Material Split, Cut or Torn (4008)
|
Patient Problem
Hemorrhage/Bleeding (1888)
|
Event Date 09/08/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
On (b)(6) 2023, a patient underwent femoro-crural bypass surgery using a gore® propaten® vascular graft.On (b)(6) 2023, four days after the implant procedure, reportedly the graft had a smooth tear 2 cm distal to the proximal anastomosis to the common femoral artery.The patient experienced massive bleeding from the groin with hemorrhagic shock, resuscitation, and emergency surgery to replace the proximal bypass portion.It was reported the patient is no longer in the intensive care unit (icu).The leg was perfused and preserved, and the wounds are closed.
|
|
Manufacturer Narrative
|
A review of the manufacturing records indicated the lot met all pre-release specifications.Neither clinical images enabling direct assessment of product performance nor the product itself were returned for evaluation.
|
|
Search Alerts/Recalls
|
|
|